Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q36085597)
Watch
English
The effects of orlistat on metabolic parameters and other cardiovascular risk factors.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
The effects of orlistat on metabolic parameters and other cardiovascular risk factors
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
author
Theodosios D. Filippatos
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
Moses Elisaf
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
author name string
D N Kiortsis
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
publication date
1 February 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
published in
Diabetes and Metabolism
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
volume
31
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
page(s)
15-22
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
cites work
Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orlistat: its current status as an anti-obesity drug
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orlistat in the long-term treatment of obesity in primary care settings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Administration of orlistat in a patient with familial hyperchylomicronemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Usefulness of Orlistat in the treatment of severe hypertriglyceridemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orlistat inhibits dietary cholesterol absorption
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular risk associated with the metabolic syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lipoprotein A levels after intestinal bypass operation for morbid obesity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Obesity, haemostasis and the fibrinolytic system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Weight change and blood coagulability and fibrinolysis in healthy obese women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammation: the link between insulin resistance, obesity and diabetes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Raised interleukin-6 levels in obese patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term orlistat treatment does not affect mineral balance and bone turnover in obese men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Effect of Short-Term (21-Day) Orlistat Treatment on the Physiologic Balance of Six Selected Macrominerals and Microminerals in Obese Adolescents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970161-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1262-3636(07)70161-1
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
PubMed ID
15803108
1 reference
stated in
Europe PubMed Central
PubMed ID
15803108
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15803108%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit